✦ LIBER ✦

Oral etoposide in the management of malignant pleural mesotheliomas phase II study

✍ Scribed by Kaukel, E; Koschel, G; Gatzemeier, U; Pawel, J v; Beckmann, L

Book ID: 123283211
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 170 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91537-U

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

48 Phase II trials of etoposide in malig

48 Phase II trials of etoposide in malignant pleural mesothelioma

✍ Sahmoud, T.; Postmus, P.E.; van Pottelsberghe, Ch.; Mattson, K.; Tammilehto, L.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Phase II Study of Intravenous Doxil® in

Phase II Study of Intravenous Doxil® in Malignant Pleural Mesothelioma

✍ Yun Oh; Roman Perez-Soler; Frank V. Fossella; Bonnie S. Glisson; Jonathan Kurie; 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 35 KB

A phase II study of pirarubicin in malig

A phase II study of pirarubicin in malignant pleural mesothelioma

✍ E. Kaukel; G. Koschel; U. Gatzemeyer; E. Salewski 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 3 views

Etoposide in malignant pleural mesotheli

Etoposide in malignant pleural mesothelioma: Two phase II trials of the EORTC lung cancer cooperative group

✍ T. Sahmoud; P.E. Postmus; Ch. van Pottelsberghe; K. Mattson; L. Tammilehto; T.A. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 549 KB

Multicentre phase II study of gemcitabin

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma

✍ van Haarst, J M W; Baas, P; Manegold, C h; Schouwink, J H; Burgers, J A; de Brui 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo